Llene, por favor, este formulario y responderemos lo más pronto posible.
Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old.
On December 13, 2016, the Mexican Senate approved a proposal submitted by Mexican President, Enrique Peña Nieto, to authorize cannabis for medicinal use. The Bill, introduced on April 21, 2016, sought to legalize cannabis for personal use, including investigational activities, as well as to grant marketing authorizations for medicines in which the active ingredient is tetrahydrocannabinol (THC). The legislation would require some modifications to the General Health Law and the Federal Criminal Code in order to become law.
The Bill is still pending approval by the lower chamber of the Mexican Congress, but considering the judicial precedents handed down recently by the Mexican Supreme Court of Justice (SCJ) and other Federal Courts, there is a strong probability that the lower chamber will approve the Bill as well.
Olivares is handling several cases in which the firm is contesting COFEPRIS's refusal to grant marketing authorization for pharmaceutical products containing cannabis and other narcotics as active ingredients.
While the Senate's approval is a significant step, we are only half way through the process of having cannabis authorized for medical use in Mexico.
Partners and Associates of our firm will continue to follow developments on this Bill.
Partner
Partner
Partner
Partner
